HomeNV40 • FRA
add
Cellectar Biosciences Inc
Nakaraang pagsara
€0.25
Sakop ng taon
€0.25 - €84.60
Market cap
12.85M USD
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga balita tungkol sa merkado
MSN
2 oras ang nakalipas
Global Markets Weekly Update. U.S. Job Growth Surprises to the Upside in June
0.83%
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 6.40M | -46.67% |
Net na kita | -6.60M | 75.21% |
Net profit margin | — | — |
Kita sa bawat share | -4.20 | 81.08% |
EBITDA | -6.34M | 46.74% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 13.91M | -65.26% |
Kabuuang asset | 16.04M | -62.61% |
Kabuuang sagutin | 6.41M | -77.93% |
Kabuuang equity | 9.64M | — |
Natitirang share | 1.54M | — |
Presyo para makapag-book | 0.05 | — |
Return on assets | -77.09% | — |
Return on capital | -121.78% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -6.60M | 75.21% |
Cash mula sa mga operasyon | -9.38M | 29.77% |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | -9.38M | -130.80% |
Malayang cash flow | -6.78M | -59.37% |
Tungkol
Itinatag
1996
Headquarters
Website
Mga Empleyado
11
